Pharmacogenetics (PGx) is a rapidly growing field of medicine that combines genetics with pharmacology.
It is widely known that patients’ responses to drugs vary due to individual genetic differences.
Liver enzymes control the metabolism of many pharmaceuticals, and variations in the expression of these enzymes can alter the rate at which drugs are metabolised. Fast metabolism is often related to poor effect of the drug and slow metabolism can cause unnecessary adverse drug reactions.
These variations can be predicted through pharmacogenetic testing, making it possible to adjust medication to fit each patient’s particular metabolic phenotype. This allows for safer and more effective medication for everyone.
We offer a comprehensive solution to accessing and utilising the information gained through pharmacogenetic testing and can support you throughout every stage of planning and implementing your PGx test panel.
Read how Abomics' solution works together with Thermo Fisher's devices.
This white paper covers how a PGx solution is built in practice, how information moves smoothly from the customer's lab visit to the doctor's desk, what kind of equipment you should choose, and which genes are essential to include in a PGx solution.
Read how Abomics' solution works together with Agena Bioscience's devices.
This white paper covers how a PGx solution is built in practice, how information moves smoothly from the customer's lab visit to the doctor's desk, what kind of equipment you should choose, and which genes are essential to include in a PGx solution.
Read how Abomics' solution works together with Pac Bio's devices.
This white paper covers how a PGx solution is built in practice, how information moves smoothly from the customer's lab visit to the doctor's desk, what kind of equipment you should choose, and which genes are essential to include in a PGx solution.
Abomics, Abomics PGx, GeneRx, GeneAccount are registered or non-registered trademarks of Abomics Oy in various countries.
